Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Assets under management requirements are becoming a high hurdle for early-career advisors looking for a new role.
A new division will connect the firms’ wealthiest clients with other products and services on the Bank of America platform.
Owning a Rolls-Royce is pretty good. But is it really that impressive when you could have a unique Rolls-Royce?